Societal costs and benefits of treatment with trastuzumab in patients with early HER2neu-overexpressing breast cancer in Singapore

Gilberto de Lima Lopes

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Societal costs and benefits of treatment with trastuzumab in patients with early HER2neu-overexpressing breast cancer in Singapore'. Together they form a unique fingerprint.

Medicine & Life Sciences